- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 31, 2025 | 143.27M sh |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $87.69M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $83.85M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $227.16M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $218.77M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $1.65B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $1.68B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $771.65M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $723.84M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $392.04M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $377.33M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $17.32B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $17.38B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 147.91M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $49.46M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $43.94M |
| Capex restated | Q1 2025 · Mar 31, 2024 | $79.28M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $220.12M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.89 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.90 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $41.33M |
| Net Income | Q1 2025 · Mar 31, 2024 | $131.3M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $232.2M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $274.21M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $771.17M |
| Revenue | Q1 2025 · Mar 31, 2024 | $1.05B |